Lv5
804 积分 2024-03-13 加入
Targeting KAT6A/B as a New Therapeutic Strategy for Cancer Therapy
5天前
已完结
Dancing with KAT6A: Current advances and therapeutic potential in oncology of KAT6A inhibitors
6天前
已完结
Highlights of ESCMID Global 2025
11天前
已完结
Lessons learned in linking PROTACs from discovery to the clinic
1个月前
已完结
A targeted combination therapy achieves effective pancreatic cancer regression and prevents tumor resistance
1个月前
已完结
Promise and Challenge of β-Lactone Electrophiles to Target Aspartate 12 of Mutant KRASG12D
1个月前
已完结
An Analysis of Successful Hit-to-Clinical Candidate Pairs
1个月前
已完结
Combining a first-in-class SLAMF7 antibody with SIRPα blockade for anti-tumor immunity
2个月前
已完结
Macrocycles and Acyclic Cucurbit[n]urils as Pseudo[2]catenane Partners for Long-Acting Neuromuscular Blocks and Rapid Reversal In Vivo
2个月前
已完结
Cu(I)-mediated modular approach for the synthesis of febuxostat and its analogues
2个月前
已完结
皖公网安备34019202002308
